Comparison of Ensemble and Single Molecule Methods for Particle Characterization and Binding Analysis of a PEGylated Single‐Domain Antibody. Issue 12 (7th September 2015)

• Record Type: Journal Article
• Authors: Schneeweis, Lumelle A.; Obenauer‐Kutner, Linda; Kaur, Parminder; Yamniuk, Aaron P.; Tamura, James; Jaffe, Neil; O'Mara, Brian W.; Lindsay, Stuart; Doyle, Michael; Bryson, James
• Is Part Of: Journal of pharmaceutical sciences. Volume 104:Issue 12(2015:Dec.)
• Page Start: 4015
• Page End: 4024
• Publication Date: 2015-09-07
• Subjects: proteins -- PEGylation -- microscopy -- light scattering (static) -- calorimetry (ITC); Pharmacy -- Periodicals; 615.1
• DOI: 10.1002/jps.24624
• Languages: English
• ISSNs: 0022-3549

Abstract

Abstract : Domain antibodies (dAbs) are single immunoglobulin domains that form the smallest functional unit of an antibody. This study investigates the behavior of these small proteins when covalently attached to the polyethylene glycol (PEG) moiety that is necessary for extending the half‐life of a dAb. The effect of the 40 kDa PEG on hydrodynamic properties, particle behavior, and receptor binding of the dAb has been compared by both ensemble solution and surface methods [light scattering, isothermal titration calorimetry (ITC), surface Plasmon resonance (SPR)] and single‐molecule atomic force microscopy (AFM) methods (topography, recognition imaging, and force microscopy). The large PEG dominates the properties of the dAb–PEG conjugate such as a hydrodynamic radius that corresponds to a globular protein over four times its size and a much reduced association rate. We have used AFM single‐molecule studies to determine the mechanism of PEG‐dependent reductions in the effectiveness of the dAb observed by SPR kinetic studies. Recognition imaging showed that all of the PEGylated dAb molecules are active, suggesting that some may transiently become inactive if PEG sterically blocks binding. This helps explain the disconnect between the SPR, determined kinetically, and the force microscopy and ITC results that demonstrated that PEG does not change the binding energy. © 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:4015–4024, 2015